RASAL3 and prostate carcinoma: In prostate cancer, Mishra et al. show that hyperactivation of the RAS signaling pathway in CAFs via epigenetic silencing of Ras-activating Protein-like 3 (RASAL3) induces macropinocytosis and lysosomal catabolism of albumin, generating glutamine.